ArticleJournal of molecular histology2026
High MMP14 and low decorin expression correlate with disease progression and metastasis in Brazilian prostate cancer patients.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer (PCa) remains a highly prevalent malignancy and a leading cause of cancer-related mortality, frequently attributed to late-stage diagnosis. Matrix metalloproteinase 14 (MMP14) and Decorin (DCN) are key extracellular matrix (ECM) components essential for tissue remodeling and tumor suppression. This study evaluated the immunohistochemical expression of MMP14 and DCN in relation to clinicopathological parameters in PCa tissue samples (n = 92), specifically examining the malignant epithelium, adjacent non-tumor tissue, and peritumoral stroma. High MMP14 expression in tumor cells was predominant in metastatic patients and significantly associated with the presence of metastases (p = 0.012), with overexpression observed in 60% of these cases. Conversely, diminished DCN staining in the peritumoral ECM was linked to metastatic disease (63% low expression). Furthermore, a significant correlation was identified between low stromal DCN expression and ISUP grades 4-5 (p = 0.047; 66% of high-grade cases). Multivariate analysis confirmed that MMP14 expression profile serves as an independent predictor of metastasis (p = 0.01). In conclusion, our findings suggest that ECM remodeling, driven by dysregulation of MMP14 and DCN, plays a pivotal role in PCa progression, highlighting their potential as prognostic biomarkers for patient stratification and therapeutic guidance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.